GlassScriptPhysician profile
Charles A Hope
NPI 1588637870
$120,605.28
in general payments reported to CMS, 2019-2025
25 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $5,375 · 2021: $1,166 · 2022: $17K · 2023: $38K · 2024: $22K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Travel and Lodging: $13K · Food and Beverage: $6,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,975.00 |
| Travel and Lodging | $12,937.81 |
| Food and Beverage | $6,220.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $99,765.72 | 2019-2025 | Mako, Accolade, Insignia |
| Omnilife Science, INC | $17,806.09 | 2022-2025 | Omnibotics 3.0, Various Products |
| Osteoremedies, LLC | $1,158.40 | 2019-2023 | Remedy Spacer, Osteoboost Select 10cc |
| Globus Medical, INC. | $278.18 | 2022-2023 | Providence |
| Smith+Nephew, INC. | $167.56 | 2024 | Journey II, Real Intelligence |
| Microport Orthopedics INC | $160.48 | 2019-2021 | |
| Medtronic, INC. | $127.27 | 2024 | Aquamantys(Tm) |
| Linkbio Corp | $126.87 | 2025 | |
| Conmed Corporation | $116.73 | 2019 | |
| Acacia Pharma INC | $115.38 | 2022 | |
| Depuy Synthes Sales INC. | $108.16 | 2022 | |
| Nextstep Arthropedix, LLC | $106.84 | 2022 | |
| Davol INC. | $96.21 | 2024 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $92.79 | 2022-2023 | Zynrelef |
| Innovation Technologies INC | $76.44 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $57.49 | 2020-2025 | Zilretta, Iovera, Exparel |
| Medacta USA, INC. | $45.58 | 2022 | |
| Pacira Therapeutics, INC. | $40.06 | 2019 | |
| Convatec INC. | $35.19 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $27.63 | 2024 | Caldolor |
| Avanos Medical | $24.99 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $23.19 | 2025 | |
| Novo Nordisk INC | $22.02 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $15.10 | 2019 | |
| Arthrosurface Incorporated | $10.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.